Study of angiotensin II-induced hypertensive chemotherapy for ovarian-cancer in rats

Oncology Reports

Volumn 4, Issue 1, 1997, Pages 93-96

  Nishimura, Haruo ^a  

^a KURUME UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Angiotensin II; Hypertensive chemotherapy; Ovarian cancer

Indexed keywords

ANGIOTENSIN; CISPLATIN; DIMETHYLBENZ[A]ANTHRACENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; RAT; TUMOR BLOOD FLOW;

EID: 0031027913     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.1.93     Document Type: Article

References (3)

1. Suzuki M, Hori K, Abe I and Saito H: A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II. J Natl Cancer Inst 67: 663-669, 1981.
2. Kohno Y, Iwanari O and Kitao M: Prognostic importance of histologie vascular density in cervical cancer treated with hypertensive intraarterial chemotherapy. Cancer 72: 2394-2400, 1993.
3. Morita T, Takahashi K and Yoshikawa H: Intraarterial infusion chemotherapy with [Sarl, Iler8] angiotensin II for bladder cancer. Amer J Clin Oncol 15:188-193, 1992.